Biogen Gross Profit 2010-2024 | BIIB

Biogen annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Biogen gross profit for the quarter ending September 30, 2024 was $1.827B, a 2.33% decline year-over-year.
  • Biogen gross profit for the twelve months ending September 30, 2024 was $7.262B, a 3.26% decline year-over-year.
  • Biogen annual gross profit for 2023 was $7.302B, a 7.51% decline from 2022.
  • Biogen annual gross profit for 2022 was $7.895B, a 11.01% decline from 2021.
  • Biogen annual gross profit for 2021 was $8.872B, a 23.78% decline from 2020.
Biogen Annual Gross Profit
(Millions of US $)
2023 $7,302
2022 $7,895
2021 $8,872
2020 $11,639
2019 $12,423
2018 $11,637
2017 $10,644
2016 $9,970
2015 $9,523
2014 $8,532
2013 $6,075
2012 $4,971
2011 $4,582
2010 $4,316
2009 $3,995
Biogen Quarterly Gross Profit
(Millions of US $)
2024-09-30 $1,827
2024-06-30 $1,919
2024-03-31 $1,748
2023-12-31 $1,768
2023-09-30 $1,871
2023-06-30 $1,863
2023-03-31 $1,800
2022-12-31 $1,973
2022-09-30 $2,039
2022-06-30 $2,105
2022-03-31 $1,778
2021-12-31 $2,074
2021-09-30 $2,267
2021-06-30 $2,315
2021-03-31 $2,216
2020-12-31 $2,362
2020-09-30 $2,927
2020-06-30 $3,271
2020-03-31 $3,080
2019-12-31 $3,224
2019-09-30 $3,170
2019-06-30 $3,140
2019-03-31 $2,888
2018-12-31 $3,038
2018-09-30 $2,978
2018-06-30 $2,936
2018-03-31 $2,685
2017-12-31 $2,798
2017-09-30 $2,708
2017-06-30 $2,712
2017-03-31 $2,426
2016-12-31 $2,494
2016-09-30 $2,539
2016-06-30 $2,524
2016-03-31 $2,414
2015-12-31 $2,507
2015-09-30 $2,468
2015-06-30 $2,306
2015-03-31 $2,243
2014-12-31 $2,343
2014-09-30 $2,209
2014-06-30 $2,130
2014-03-31 $1,851
2013-12-31 $1,707
2013-09-30 $1,593
2013-06-30 $1,493
2013-03-31 $1,281
2012-12-31 $1,284
2012-09-30 $1,246
2012-06-30 $1,282
2012-03-31 $1,159
2011-12-31 $1,187
2011-09-30 $1,186
2011-06-30 $1,108
2011-03-31 $1,100
2010-12-31 $1,119
2010-09-30 $1,080
2010-06-30 $1,106
2010-03-31 $1,012
2009-12-31 $1,027
2009-09-30 $1,027
2009-06-30 $1,003
2009-03-31 $938
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $23.407B $9.836B
Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement disorders including Parkinson's disease, neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) and ophthalmology. Key multiple sclerosis/MS drugs in its portfolio are Tecfidera, Vumerity, Avonex, Plegridy, Fampyra and Tysabri. Other approved/marketed products include Fumaderm (severe psoriasis), Spinraza (spinal muscular atrophy (SMA)) and Aduhelm (Alzheimer's disease).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $152.052B 14.72
Vertex Pharmaceuticals (VRTX) United States $120.557B 0.00
Bristol Myers Squibb (BMY) United States $120.109B 50.62
Gilead Sciences (GILD) United States $115.379B 20.90
CSL (CSLLY) Australia $88.978B 0.00
Regeneron Pharmaceuticals (REGN) United States $82.441B 18.76
GSK (GSK) United Kingdom $70.736B 8.18
Argenex SE (ARGX) Netherlands $37.220B 0.00
Alnylam Pharmaceuticals (ALNY) United States $32.641B 0.00
BioNTech SE (BNTX) Germany $28.383B 0.00
Illumina (ILMN) United States $22.862B 83.32
BeiGene (BGNE) Cayman Islands $20.940B 0.00
Moderna (MRNA) United States $16.570B 0.00
Incyte (INCY) United States $14.370B 0.00
Genmab (GMAB) Denmark $14.228B 20.87
Insmed (INSM) United States $13.446B 0.00
Sarepta Therapeutics (SRPT) United States $12.737B 114.95
BioMarin Pharmaceutical (BMRN) United States $12.584B 29.22
Bio-Techne Corp (TECH) United States $11.974B 46.23
Vaxcyte (PCVX) United States $11.758B 0.00
Exact Sciences (EXAS) United States $11.490B 0.00
Exelixis (EXEL) United States $10.412B 23.67
QIAGEN (QGEN) Netherlands $9.911B 20.39
Revolution Medicines (RVMD) United States $9.731B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.407B 31.97
Roivant Sciences (ROIV) United Kingdom $9.252B 0.00
Intra-Cellular Therapies (ITCI) United States $9.080B 0.00
Repligen (RGEN) United States $8.434B 109.88
Ascendis Pharma (ASND) Denmark $8.252B 0.00
Legend Biotech (LEGN) United States $7.718B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.351B 7.19
Nuvalent (NUVL) United States $6.869B 0.00
Halozyme Therapeutics (HALO) United States $6.132B 13.85
Blueprint Medicines (BPMC) United States $6.123B 0.00
Cytokinetics (CYTK) United States $6.120B 0.00
Viking Therapeutics (VKTX) United States $5.899B 0.00
Krystal Biotech (KRYS) United States $5.678B 94.01
Telix Pharmaceuticals (TLX) $5.520B 0.00
TG Therapeutics (TGTX) United States $5.417B 0.00
Avidity Biosciences (RNA) United States $5.134B 0.00
Arcellx (ACLX) United States $4.762B 0.00
Axsome Therapeutics (AXSM) United States $4.760B 0.00
ADMA Biologics Inc (ADMA) United States $4.754B 50.28
Alkermes (ALKS) Ireland $4.696B 15.77
Biohaven (BHVN) United States $4.653B 0.00
Guardant Health (GH) United States $4.400B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.398B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.368B 0.00
Apellis Pharmaceuticals (APLS) United States $4.221B 0.00
Immunovant (IMVT) United States $4.139B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.813B 0.00
Scholar Rock Holding (SRRK) United States $3.735B 0.00
Denali Therapeutics (DNLI) United States $3.598B 0.00
ImmunityBio (IBRX) United States $3.512B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.478B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.250B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.239B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.168B 0.00
Vera Therapeutics (VERA) United States $3.150B 0.00
Zai Lab (ZLAB) China $3.134B 0.00
Edgewise Therapeutics (EWTX) United States $3.125B 0.00
SpringWorks Therapeutics (SWTX) United States $3.086B 0.00
Merus (MRUS) Netherlands $3.070B 0.00
Kymera Therapeutics (KYMR) United States $3.034B 0.00
Amicus Therapeutics (FOLD) United States $2.982B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.955B 0.00
Twist Bioscience (TWST) United States $2.919B 0.00
Vericel (VCEL) United States $2.870B 969.00
Iovance Biotherapeutics (IOVA) United States $2.841B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.716B 20.92
Protagonist Therapeutics (PTGX) United States $2.610B 16.47
Geron (GERN) United States $2.491B 0.00
Janux Therapeutics (JANX) United States $2.373B 0.00
IDEAYA Biosciences (IDYA) United States $2.365B 0.00
CG Oncology (CGON) United States $2.350B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.342B 0.00
Keros Therapeutics (KROS) United States $2.339B 0.00
WAVE Life Sciences (WVE) Singapore $2.303B 0.00
Ligand Pharmaceuticals (LGND) United States $2.295B 57.30
NeoGenomics (NEO) United States $2.276B 0.00
Beam Therapeutics (BEAM) United States $2.266B 0.00
Akero Therapeutics (AKRO) United States $2.241B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.219B 0.00
NovoCure (NVCR) Jersey $2.168B 0.00
Bavarian Nordic (BVNRY) Denmark $2.152B 13.19
Apogee Therapeutics (APGE) United States $2.033B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.005B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.977B 16.43
Belite Bio (BLTE) United States $1.937B 0.00
Structure Therapeutics (GPCR) United States $1.898B 0.00
Fortrea Holdings (FTRE) United States $1.888B 60.14
Disc Medicine (IRON) United States $1.888B 0.00
MannKind (MNKD) United States $1.870B 48.43
Arvinas (ARVN) United States $1.836B 0.00
Galapagos (GLPG) Belgium $1.821B 0.00
Celldex Therapeutics (CLDX) United States $1.820B 0.00
Certara (CERT) United States $1.805B 50.96
Viridian Therapeutics (VRDN) United States $1.707B 0.00
Dynavax Technologies (DVAX) United States $1.691B 98.92
Immunocore Holdings (IMCR) United Kingdom $1.638B 0.00
Neumora Therapeutics (NMRA) United States $1.606B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.594B 0.00
Intellia Therapeutics (NTLA) United States $1.591B 0.00
Nurix Therapeutics (NRIX) United States $1.566B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.526B 0.00
Praxis Precision Medicines (PRAX) United States $1.494B 0.00
Myriad Genetics (MYGN) United States $1.481B 0.00
Travere Therapeutics (TVTX) United States $1.468B 0.00
Spyre Therapeutics (SYRE) United States $1.462B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.427B 0.00
Arcus Biosciences (RCUS) United States $1.413B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.405B 0.00
Novavax (NVAX) United States $1.397B 0.00
MiMedx (MDXG) United States $1.359B 35.58
Mesoblast (MESO) Australia $1.335B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.312B 0.00
ANI Pharmaceuticals (ANIP) United States $1.203B 16.40
Upstream Bio (UPB) United States $1.172B 0.00
Gyre Therapeutics (GYRE) United States $1.170B 0.00
Bicara Therapeutics (BCAX) United States $1.131B 0.00
Septerna (SEPN) United States $1.123B 0.00
Vir Biotechnology (VIR) United States $1.096B 0.00
Cogent Biosciences (COGT) United States $1.050B 0.00
ArriVent BioPharma (AVBP) United States $1.010B 0.00
Immatics (IMTX) Germany $0.993B 0.00
LENZ Therapeutics (LENZ) United States $0.979B 0.00
Liquidia Technologies (LQDA) United States $0.978B 0.00
Nuvation Bio (NUVB) United States $0.976B 0.00
Zymeworks (ZYME) United States $0.970B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.970B 0.00
Replimune (REPL) United States $0.963B 0.00
89BIO (ETNB) United States $0.954B 0.00
Poseida Therapeutics (PSTX) United States $0.907B 0.00
AbCellera Biologics (ABCL) Canada $0.889B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.883B 0.00
Adaptive Biotechnologies (ADPT) United States $0.877B 0.00
Prothena (PRTA) Ireland $0.872B 0.00
Kura Oncology (KURA) United States $0.859B 0.00
Castle Biosciences (CSTL) United States $0.848B 151.40
Immunome (IMNM) United States $0.846B 0.00
Cytek Biosciences (CTKB) United States $0.841B 0.00
Pliant Therapeutics (PLRX) United States $0.840B 0.00
CARGO Therapeutics (CRGX) United States $0.837B 0.00
Rapport Therapeutics (RAPP) United States $0.835B 0.00
Erasca (ERAS) United States $0.809B 0.00
Anavex Life Sciences (AVXL) United States $0.802B 0.00
Tyra Biosciences (TYRA) United States $0.793B 0.00
Avid Bioservices (CDMO) United States $0.783B 0.00
Cullinan Therapeutics (CGEM) United States $0.783B 0.00
Pacira BioSciences (PCRX) United States $0.781B 7.35
AnaptysBio (ANAB) United States $0.760B 0.00
Entrada Therapeutics (TRDA) United States $0.744B 12.51
Tectonic Therapeutic (TECX) United States $0.734B 0.00
Dianthus Therapeutics (DNTH) United States $0.710B 0.00
Oric Pharmaceuticals (ORIC) United States $0.699B 0.00
MBX Biosciences (MBX) United States $0.680B 0.00
BioAge Labs (BIOA) United States $0.674B 0.00
Arbutus Biopharma (ABUS) United States $0.656B 0.00
Oculis Holding AG (OCS) Switzerland $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
CureVac (CVAC) Germany $0.643B 5.22
Stoke Therapeutics (STOK) United States $0.641B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.636B 0.00
Mineralys Therapeutics (MLYS) United States $0.636B 0.00
Sana Biotechnology (SANA) United States $0.621B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.607B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.604B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
CorMedix Inc (CRMD) United States $0.598B 0.00
IGM Biosciences (IGMS) United States $0.597B 0.00
ChromaDex (CDXC) United States $0.590B 772.00
GRAIL (GRAL) United States $0.588B 0.00
Astria Therapeutics (ATXS) United States $0.586B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.584B 0.00
Olema Pharmaceuticals (OLMA) United States $0.580B 0.00
Third Harmonic Bio (THRD) United States $0.575B 0.00
Annexon (ANNX) United States $0.575B 0.00
Humacyte (HUMA) United States $0.569B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.559B 0.00
Emergent Biosolutions (EBS) United States $0.548B 0.00
Abivax SA (ABVX) France $0.540B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.534B 0.00
PureTech Health (PRTC) United States $0.532B 0.00
Terns Pharmaceuticals (TERN) United States $0.530B 0.00
MeiraGTx Holdings (MGTX) United States $0.529B 0.00
Allogene Therapeutics (ALLO) United States $0.520B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.501B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.500B 0.00
Pharming Group (PHAR) Netherlands $0.499B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.497B 0.00
REGENXBIO (RGNX) United States $0.491B 0.00
Zenas BioPharma (ZBIO) United States $0.481B 0.00
Cartesian Therapeutics (RNAC) United States $0.479B 0.00
Celcuity (CELC) United States $0.475B 0.00
Sangamo Therapeutics (SGMO) United States $0.472B 0.00
Aura Biosciences (AURA) United States $0.465B 0.00
GH Research (GHRS) Ireland $0.465B 0.00
ACELYRIN, INC (SLRN) United States $0.456B 0.00
Foghorn Therapeutics (FHTX) United States $0.444B 0.00
Alumis (ALMS) United States $0.437B 0.00
Prime Medicine (PRME) United States $0.432B 0.00
Tango Therapeutics (TNGX) United States $0.423B 0.00
Alpha Teknova (TKNO) United States $0.398B 0.00
XOMA Royalty (XOMA) United States $0.394B 0.00
Contineum Therapeutics (CTNM) United States $0.384B 0.00
EnGene Holdings (ENGN) Canada $0.382B 0.00
Revance Therapeutics (RVNC) United States $0.379B 0.00
Neurogene (NGNE) United States $0.378B 0.00
Voyager Therapeutics (VYGR) United States $0.375B 9.66
MaxCyte (MXCT) United States $0.374B 0.00
Codexis (CDXS) United States $0.373B 0.00
Northwest Biotherapeutics (NWBO) United States $0.371B 0.00
Fate Therapeutics (FATE) United States $0.361B 0.00
Kodiak Sciences (KOD) United States $0.351B 0.00
Absci (ABSI) United States $0.350B 0.00
Eton Pharmaceuticals (ETON) United States $0.350B 0.00
Jasper Therapeutics (JSPR) United States $0.342B 0.00
Design Therapeutics (DSGN) United States $0.340B 0.00
Kamada (KMDA) Israel $0.339B 21.04
AC Immune (ACIU) Switzerland $0.336B 0.00
Q32 Bio (QTTB) United States $0.328B 0.00
C4 Therapeutics (CCCC) United States $0.321B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.314B 0.00
ITeos Therapeutics (ITOS) United States $0.312B 0.00
Artiva Biotherapeutics (ARTV) United States $0.310B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.300B 0.00
Urogen Pharma (URGN) United States $0.298B 0.00
ATyr Pharma (ATYR) United States $0.296B 0.00
Prima BioMed (IMMP) Australia $0.295B 0.00
Rezolute (RZLT) United States $0.292B 0.00
UniQure (QURE) Netherlands $0.291B 0.00
Atea Pharmaceuticals (AVIR) United States $0.289B 0.00
Ocugen (OCGN) United States $0.286B 0.00
Tenaya Therapeutics (TNYA) United States $0.283B 0.00
Mersana Therapeutics (MRSN) United States $0.282B 0.00
Nautilus Biotechnology (NAUT) United States $0.281B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.278B 0.00
Abeona Therapeutics (ABEO) United States $0.278B 0.00
TuHURA Biosciences (HURA) United States $0.277B 0.00
Precigen (PGEN) United States $0.273B 0.00
Lifecore Biomedical (LFCR) United States $0.273B 0.00
Biomea Fusion (BMEA) United States $0.262B 0.00
Anika Therapeutics (ANIK) United States $0.260B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.257B 0.00
TScan Therapeutics (TCRX) United States $0.255B 0.00
Alector (ALEC) United States $0.254B 0.00
Kyverna Therapeutics (KYTX) United States $0.249B 0.00
DiaMedica Therapeutics (DMAC) United States $0.242B 0.00
Verastem (VSTM) United States $0.238B 0.00
Applied Therapeutics (APLT) United States $0.236B 0.00
Molecular Partners AG (MOLN) Switzerland $0.235B 0.00
Benitec Biopharma (BNTC) United States $0.234B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.234B 0.00
XBiotech (XBIT) United States $0.232B 0.00
BioStem Technologies (BSEM) $0.231B 20.40
Semper Paratus Acquisition (TVGN) United States $0.229B 0.00
Solid Biosciences (SLDB) United States $0.228B 0.00
Compass Therapeutics (CMPX) United States $0.224B 0.00
Trevi Therapeutics (TRVI) United States $0.221B 0.00
Inhibrx Biosciences (INBX) United States $0.221B 0.00
Sutro Biopharma (STRO) United States $0.219B 0.00
Climb Bio (CLYM) United States $0.217B 0.00
Opthea (OPT) Australia $0.215B 0.00
Checkpoint Therapeutics (CKPT) United States $0.214B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Amarin (AMRN) Ireland $0.208B 0.00
Fulcrum Therapeutics (FULC) United States $0.208B 0.00
2seventy Bio (TSVT) United States $0.206B 0.00
Nkarta (NKTX) United States $0.203B 0.00
Zura Bio (ZURA) United States $0.199B 0.00
Caribou Biosciences (CRBU) United States $0.198B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.198B 0.00
Bright Minds Biosciences (DRUG) United States $0.195B 0.00
Ventyx Biosciences (VTYX) United States $0.190B 0.00
Greenwich LifeSciences (GLSI) United States $0.187B 0.00
Cabaletta Bio (CABA) United States $0.187B 0.00
Editas Medicine (EDIT) United States $0.185B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.184B 0.00
ScPharmaceuticals (SCPH) United States $0.181B 0.00
Instil Bio (TIL) United States $0.176B 0.00
Sagimet Biosciences (SGMT) United States $0.175B 0.00
Inozyme Pharma (INZY) United States $0.174B 0.00
Seres Therapeutics (MCRB) United States $0.167B 0.00
Puma Biotechnology (PBYI) United States $0.166B 7.06
Adherex Technologies (FENC) United States $0.166B 0.00
PepGen (PEPG) United States $0.165B 0.00
Actuate Therapeutics (ACTU) United States $0.159B 0.00
Gossamer Bio (GOSS) United States $0.158B 0.00
Candel Therapeutics (CADL) United States $0.153B 0.00
Black Diamond Therapeutics (BDTX) United States $0.150B 0.00
Seer (SEER) United States $0.146B 0.00
InflaRx (IFRX) Germany $0.145B 0.00
Elutia (ELUT) United States $0.143B 0.00
Cidara Therapeutics (CDTX) United States $0.142B 0.00
Compugen (CGEN) Israel $0.142B 79.50
Coherus BioSciences (CHRS) United States $0.141B 0.00
Repare Therapeutics (RPTX) Canada $0.139B 0.00
Inventiva S.A (IVA) France $0.139B 0.00
Adverum Biotechnologies (ADVM) United States $0.138B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.136B 0.00
Skye Bioscience (SKYE) United States $0.136B 0.00
Cardiff Oncology (CRDF) United States $0.133B 0.00
Innate Pharma S.A (IPHA) France $0.125B 0.00
TELA Bio (TELA) United States $0.124B 0.00
Scilex Holding (SCLX) United States $0.123B 0.00
Renovaro (RENB) United States $0.120B 0.00
Alto Neuroscience (ANRO) United States $0.119B 0.00
Monopar Therapeutics (MNPR) United States $0.119B 0.00
Cellectis S.A (CLLS) France $0.117B 0.00
Rani Therapeutics Holdings (RANI) United States $0.116B 0.00
Leap Therapeutics (LPTX) United States $0.114B 0.00
Inovio Pharmaceuticals (INO) United States $0.113B 0.00
INmune Bio (INMB) United States $0.112B 0.00
Immunic (IMUX) United States $0.112B 0.00
Akoya Biosciences (AKYA) United States $0.109B 0.00
Coya Therapeutics (COYA) United States $0.109B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.106B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
Adagene (ADAG) China $0.103B 0.00
Generation Bio (GBIO) United States $0.102B 0.00
MediciNova (MNOV) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Vigil Neuroscience (VIGL) United States $0.101B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.100B 0.00
Nuvectis Pharma (NVCT) United States $0.097B 0.00
CAMP4 Therapeutics (CAMP) United States $0.097B 0.00
HilleVax (HLVX) United States $0.096B 0.00
Genenta Science S.p.A (GNTA) Italy $0.095B 0.00
Adicet Bio (ACET) United States $0.093B 0.00
Genelux (GNLX) United States $0.093B 0.00
23andMe Holding (ME) United States $0.093B 0.00
Annovis Bio (ANVS) United States $0.093B 0.00
Allakos (ALLK) United States $0.092B 0.00
Aligos Therapeutics (ALGS) United States $0.092B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.091B 0.00
FibroBiologics (FBLG) United States $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Werewolf Therapeutics (HOWL) United States $0.089B 0.00
Invivyd (IVVD) United States $0.084B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
CytomX Therapeutics (CTMX) United States $0.083B 6.24
Adlai Nortye (ANL) Cayman Islands $0.082B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.082B 0.00
PDS Biotechnology (PDSB) United States $0.082B 0.00
BioAtla (BCAB) United States $0.081B 0.00
Ovid Therapeutics (OVID) United States $0.081B 0.00
Agenus (AGEN) United States $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Chimerix (CMRX) United States $0.079B 0.00
VistaGen Therapeutics (VTGN) United States $0.079B 0.00
Invizyne Technologies (IZTC) $0.079B 0.00
Bluebird Bio (BLUE) United States $0.079B 0.00
ALX Oncology Holdings (ALXO) United States $0.078B 0.00
Cue Biopharma (CUE) United States $0.077B 0.00
I-Mab (IMAB) China $0.076B 0.00
Aerovate Therapeutics (AVTE) United States $0.076B 0.00
BeyondSpring (BYSI) United States $0.075B 0.00
DBV Technologies S.A (DBVT) France $0.075B 0.00
ZIVO Bioscience (ZIVO) United States $0.073B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Atara Biotherapeutics (ATRA) United States $0.070B 0.00
Passage Bio (PASG) United States $0.070B 0.00
X4 Pharmaceuticals (XFOR) United States $0.067B 0.00
CervoMed (CRVO) United States $0.067B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Exicure (XCUR) United States $0.064B 0.00
BGM Group (BGM) China $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.062B 16.29
Aileron Therapeutics (ALRN) United States $0.062B 0.00
Boundless Bio (BOLD) United States $0.061B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
IO Biotech (IOBT) Denmark $0.059B 0.00
Connect Biopharma Holdings (CNTB) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Aadi Bioscience (AADI) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Vor Biopharma (VOR) $0.057B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
OnKure Therapeutics (OKUR) United States $0.052B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Dyadic (DYAI) United States $0.051B 0.00
AN2 Therapeutics (ANTX) United States $0.050B 0.00
Omega Therapeutics (OMGA) United States $0.049B 0.00
Rallybio (RLYB) United States $0.049B 0.00
Oncobiologics (OTLK) United States $0.048B 0.00
Xilio Therapeutics (XLO) United States $0.048B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Affimed (AFMD) Germany $0.046B 0.00
Celularity (CELU) United States $0.045B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.044B 0.00
Rapt Therapeutics (RAPT) United States $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
Intensity Therapeutics (INTS) United States $0.041B 0.00
Alpha Cognition (ACOG) Canada $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Beyond Air (XAIR) United States $0.037B 0.00
Curis (CRIS) United States $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
Clene (CLNN) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Grace Therapeutics (GRCE) Canada $0.034B 0.00
NextCure (NXTC) United States $0.033B 0.00
Forte Biosciences (FBRX) United States $0.032B 0.00
KALA BIO (KALA) United States $0.032B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Longeveron (LGVN) United States $0.030B 0.00
HOOKIPA Pharma (HOOK) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.030B 0.00
Medicus Pharma (MDCX) $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Chemomab Therapeutics (CMMB) Israel $0.026B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
LakeShore Biopharma (LSB) China $0.026B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
GeoVax Labs (GOVX) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.024B 0.00
Pulmatrix (PULM) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.023B 0.00
IN8bio (INAB) United States $0.022B 0.00
Abpro Holdings (ABP) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
UNITY Biotechnology (UBX) United States $0.021B 0.00
BioAffinity Technologies (BIAF) United States $0.019B 0.00
Gelteq (GELS) Australia $0.019B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
Tenax Therapeutics (TENX) United States $0.018B 0.00
HCW Biologics (HCWB) United States $0.018B 0.00
BioXcel Therapeutics (BTAI) United States $0.017B 0.00
Cognition Therapeutics (CGTX) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
NKGen Biotech (NKGN) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Evaxion Biotech (EVAX) Denmark $0.010B 0.00
Apollomics (APLM) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Quantum Biopharma (QNTM) Canada $0.009B 0.00
Biora Therapeutics (BIOR) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Eyenovia (EYEN) United States $0.009B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Onconetix (ONCO) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
NAYA Biosciences (NAYA) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Aptose Biosciences (APTO) Canada $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00